Mustang Bio Inc. (NASDAQ: MBIO)
$0.39
-0.0116 ( -2.86% ) 541.4K
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Market Data
Open
$0.39
Previous close
$0.40
Volume
541.4K
Market cap
$12.86M
Day range
$0.39 - $0.43
52 week range
$0.13 - $5.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 14, 2023 |
10-q | Quarterly Reports | 70 | Aug 14, 2023 |
8-k | 8K-related | 17 | Jul 31, 2023 |
8-k | 8K-related | 14 | Jul 20, 2023 |
8-k | 8K-related | 12 | Jul 11, 2023 |
4 | Insider transactions | 1 | Jul 07, 2023 |
4 | Insider transactions | 1 | Jul 07, 2023 |
4 | Insider transactions | 1 | Jul 07, 2023 |
4 | Insider transactions | 1 | Jul 07, 2023 |
4 | Insider transactions | 1 | Jul 07, 2023 |